- Home
- PERI vs DCTH Comparison
PERI vs DCTH Comparison
Compare PERI & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PERI
- DCTH
- Stock Information
- Founded
- PERI 1999
- DCTH 1988
- Country
- PERI Israel
- DCTH United States
- Employees
- PERI N/A
- DCTH N/A
- Industry
- PERI EDP Services
- DCTH Medical/Dental Instruments
- Sector
- PERI Technology
- DCTH Health Care
- Exchange
- PERI Nasdaq
- DCTH Nasdaq
- Market Cap
- PERI 484.6M
- DCTH 485.5M
- IPO Year
- PERI 2006
- DCTH N/A
- Fundamental
- Price
- PERI $11.11
- DCTH $12.50
- Analyst Decision
- PERI Buy
- DCTH Strong Buy
- Analyst Count
- PERI 4
- DCTH 4
- Target Price
- PERI $11.83
- DCTH $24.00
- AVG Volume (30 Days)
- PERI 246.6K
- DCTH 785.8K
- Earning Date
- PERI 07-30-2025
- DCTH 08-04-2025
- Dividend Yield
- PERI N/A
- DCTH N/A
- EPS Growth
- PERI N/A
- DCTH N/A
- EPS
- PERI N/A
- DCTH N/A
- Revenue
- PERI $429,808,000.00
- DCTH $53,850,000.00
- Revenue This Year
- PERI N/A
- DCTH $155.42
- Revenue Next Year
- PERI $11.24
- DCTH $37.93
- P/E Ratio
- PERI N/A
- DCTH N/A
- Revenue Growth
- PERI N/A
- DCTH 1068.87
- 52 Week Low
- PERI $7.00
- DCTH $7.17
- 52 Week High
- PERI $11.79
- DCTH $18.23
- Technical
- Relative Strength Index (RSI)
- PERI 64.84
- DCTH 33.81
- Support Level
- PERI $9.28
- DCTH $13.30
- Resistance Level
- PERI $11.13
- DCTH $14.15
- Average True Range (ATR)
- PERI 0.30
- DCTH 0.64
- MACD
- PERI 0.13
- DCTH -0.26
- Stochastic Oscillator
- PERI 90.81
- DCTH 8.28
About PERI Perion Network Ltd.
Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.